Smith Karen L.
Insider CIK 1639637 · SGMO Director · ATRS Director · JAZZ Global Head of R&D and CMO · XLRN Director · SCMP Director · EBS EVP, Chief Medical Officer · SKYE Director · AUPH Director · CRTX Chief Medical Officer · TALS Director · CNTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTX Context Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2026-03-31 | 2026-04-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2026-02-06 | 2026-02-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2025-06-12 | 2025-06-12 | 123,500 | — | $0 | 123,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2025-06-12 | 2025-06-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2025-06-12 | 2025-06-16 | 25,000 | — | $0 | 102,100 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2024-11-21 | 2024-11-25 | 18,641 | — | $0 | 18,641 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2024-11-21 | 2024-11-25 | 12,135 | — | $0 | 24,807 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2024-11-11 | 2024-11-12 | 5,241 | $8.43 | $44.2K | 12,672 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 17,913 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2024-10-28 | 2024-10-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2024-09-04 | 2024-09-05 | 19,315 | — | $0 | 19,315 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2024-07-02 | 2024-07-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2024-06-04 | 2024-06-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2024-06-04 | 2024-06-06 | 25,000 | — | $0 | 77,100 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2023-08-18 | 2023-08-21 | 17,913 | — | $0 | 17,913 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2023-08-18 | 2023-08-21 | 28,959 | — | $0 | 28,959 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 20,500 | — | $0 | 20,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2023-06-01 | 2023-06-05 | 27,750 | — | $0 | 27,750 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2023-06-01 | 2023-06-05 | 13,900 | — | $0 | 52,100 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 225,000 | — | $0 | 225,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 14,501 | — | $0 | 14,501 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 48,542 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 46,729 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 58,246 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 54,193 | $5.60 | $303.5K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 25,452 | $5.60 | $142.5K | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-05-23 | 2022-05-23 | 1,365,449 | — | $0 | 1,365,449 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-05-19 | 2022-05-23 | 151,799 | — | $0 | 151,799 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-05-19 | 2022-05-23 | 24,336 | — | $0 | 24,336 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-05-19 | 2022-05-27 | 170,354 | — | $0 | 194,690 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-05-16 | 2022-05-17 | 29,002 | — | $0 | 29,002 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2022-02-25 | 2022-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2022-02-25 | 2022-03-01 | 12,500 | — | $0 | 38,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 4,085 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 1,875 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,750 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,222 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 1,622 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 48,542 | — | $0 | 48,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 25,452 | $4.42 | $112.5K | 79,645 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2021-05-07 | 2021-05-11 | 305 | $60.85 | $18.6K | 11,888 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-05 | 2021-04-05 | 5,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-05 | 2021-04-05 | 2,050 | — | $0 | 4,085 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-05 | 2021-04-05 | 1,875 | — | $0 | 3,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-05 | 2021-04-05 | 641 | $141.15 | $90.5K | 1,622 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-05 | 2021-04-05 | 5,000 | $35.34 | $176.7K | 9,561 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-05 | 2021-04-05 | 1,875 | $41.64 | $78.1K | 11,436 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-05 | 2021-04-05 | 11,223 | $140.13 | $1.57M | 2,263 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-05 | 2021-04-05 | 2,050 | $52.99 | $108.6K | 13,486 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-01 | 2021-04-02 | 2,050 | — | $0 | 6,135 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-01 | 2021-04-02 | 1,875 | — | $0 | 5,625 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-04-01 | 2021-04-02 | 5,000 | — | $0 | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 1,201 | $134.54 | $161.6K | 12,285 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-01 | 2021-04-02 | 2,050 | $52.99 | $108.6K | 13,486 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-01 | 2021-04-02 | 1,875 | $41.64 | $78.1K | 11,436 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 2,987 | $136.22 | $406.9K | 9,298 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 3,796 | $136.92 | $519.7K | 5,502 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-04-01 | 2021-04-02 | 941 | $137.92 | $129.8K | 4,561 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-04-01 | 2021-04-02 | 5,000 | $35.34 | $176.7K | 9,561 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2021-02-25 | 2021-03-01 | 16,400 | — | $0 | 16,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2021-02-25 | 2021-03-01 | 8,200 | — | $0 | 25,700 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2021-02-24 | 2021-02-26 | 11,765 | $93.49 | $1.10M | 11,765 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 2,942 | — | $0 | 9,252 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-02-24 | 2021-02-26 | 2,941 | — | $0 | 12,193 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 3,222 | — | $0 | 3,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 1,622 | — | $0 | 4,561 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 58,246 | — | $0 | 58,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 30,220 | $2.73 | $82.5K | 54,193 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-05-20 | 2,500 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-06-03 | 10,000 | — | $0 | 17,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 8,185 | — | $0 | 8,185 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 1,377 | — | $0 | 2,939 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 46,729 | — | $0 | 46,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 23,973 | $2.92 | $70.0K | 23,973 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-06-10 | 2019-06-12 | 2,500 | — | $0 | 7,500 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-03-01 | 2019-03-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 1,562 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-26 | 2018-06-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-26 | 2018-06-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2018-03-05 | 2018-03-07 | 648 | $143.39 | $92.9K | 28,474 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2018-03-01 | 2018-03-05 | 19,290 | — | $0 | 19,290 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2018-03-01 | 2018-03-05 | 710 | — | $0 | 710 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 1,875 | — | $0 | 1,875 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2018-03-01 | 2018-03-05 | 8,000 | — | $0 | 29,122 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 312 | — | $0 | 312 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2018-02-26 | 2018-02-28 | 525 | $147.44 | $77.4K | 21,122 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 30,000 | $7.05 | $211.5K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-11-15 | 2017-11-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2017-05-11 | 2017-05-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2017-05-11 | 2017-05-12 | 1,000 | — | $0 | 21,527 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2017-05-11 | 2017-05-12 | 641 | $155.18 | $99.5K | 20,527 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2017-03-02 | 2017-03-06 | 17,848 | — | $0 | 17,848 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2017-03-02 | 2017-03-06 | 902 | — | $0 | 902 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2017-03-02 | 2017-03-06 | 7,500 | — | $0 | 21,168 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2017-02-27 | 2017-03-01 | 571 | $136.97 | $78.2K | 13,668 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | P Buy | 2016-08-12 | 2016-08-12 | 607 | $137.10 | $83.2K | 14,181 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | P Buy | 2016-08-12 | 2016-08-12 | 1 | $137.26 | $137 | 14,182 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | P Buy | 2016-07-13 | 2016-07-13 | 580 | $143.63 | $83.3K | 13,574 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | P Buy | 2016-06-13 | 2016-06-15 | 557 | $149.61 | $83.3K | 12,994 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2016-05-11 | 2016-05-12 | 641 | $148.76 | $95.4K | 12,399 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2016-04-13 | 2016-04-15 | 103 | $147.34 | $15.2K | 13,040 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2016-02-25 | 2016-02-29 | 14,375 | — | $0 | 14,375 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2016-02-25 | 2016-02-29 | 625 | — | $0 | 625 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2016-02-25 | 2016-02-29 | 6,000 | — | $0 | 13,143 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2015-05-11 | 2015-05-13 | 2,264 | — | $0 | 2,264 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2015-05-11 | 2015-05-13 | 15,516 | — | $0 | 15,516 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2015-05-11 | 2015-05-13 | 6,830 | — | $0 | 6,830 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2015-05-11 | 2015-05-13 | 275 | — | $0 | 7,105 | SEC↗ |